Inflammation plays a significant role in the initiation, maintenance, and perpetuation of atrial fibrillation, with inflammatory markers correlating to longer AF duration and thrombogenesis.
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Recent studies have indicated that inflammation might play a significant role in the initiation, maintenance, and perpetuation of AF. Inflammatory markers such as interleukin-6 and C-reactive protein are elevated in AF and correlate to longer duration of AF, success of cardioversion, and thrombogenesis. Furthermore, the inflammatory process might be modulated by the use of statins, angiotensin-converting enzyme inhibitors, or glucocorticoids. The purpose of this study is to analyze the current published reports on the relationship between inflammation and AF and the potential therapeutic options available to modulate the inflammatory milieu in AF.
Issac et al. (Thu,) conducted a review in Atrial fibrillation. Inflammation was evaluated. Inflammation plays a significant role in the initiation, maintenance, and perpetuation of atrial fibrillation, with inflammatory markers correlating to longer AF duration and thrombogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: